Bangalore-based researchers develop new nanoparticle; Aphios obtains drug delivery patent;

> Researchers in Bangalore, India, have developed a nanoparticle for delivering the osteoporosis drug zoledronic acid. Story

> Aphios obtained a patent for "nanotechnology co-encapsulation of combination drugs and drug products" from the U.S. government. Release

> MiNA Therapeutics entered into an exclusive license agreement with the regents of the University of California related to intellectual property. Release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.